Harvard Medical School BostonコミュのNew Technology Presentation

New Technology Presentation – NextBio Search and Discovery
A new online tool for searching research papers and authoritative sources relative to
experimental data/conditions by gene expression, disease and/or tissue type.
Correlate your experimental data with over 4000 curated studies.


Hosted by the Department of Cell Biology, Harvard Medical School
Open to all who are interested (please forward)

Tuesday March 24, 2009
12:30 – 1:30 pm
240 Longwood Avenue, Boston
Cannon Room, Building C 114
See map ( http://www.hms.harvard.edu/about/maps/quadmap.html)
The Cannon Room is in the link between C-1 and C-2, on the ground floor.

PIZZA WILL BE SERVED


Upfront In silico Validation Impacts Experimental and Possibly Clinical Success
James Flynn, Ph.D., Field Application Scientist, NextBio

NextBio is a life sciences search and knowledge discovery engine that enables Researchers to access large scale data in ways which were never before possible. In this seminar, we will explore how principles of Integrative Biology can best be achieved in an environment that semantically links knowledge sources, where ad hoc exploration, search in essence, spans domains and stimulates hypothesis generation. Validating hypotheses, in biological terms, before experiments are run improves success in the lab. We will also discuss how achievements in cellular biology and ultimately in public health will occur more rapidly when communities utilize the data and in turn contribute knowledge towards alleviating the complications of disease.

Nextbio’s offering delivers a number of unique capabilities including:

· Access to a curated and collated repository of experimental data from an extensive set of public sources, covering a broad range of techniques and therapeutic areas.
· Automated and secure upload of internally generated experimental data and correlation with publicly available data
· Extensive tissue, disease, and compound ontologies to ensure accurate correlations
· An intuitive, researcher-friendly, web-based interface
· SaaS (Software as a Service) delivery model requiring little or no IT support

In this presentation, NextBio will be shown to break down barriers to accessing and integrating an expansive diversity of knowledge concerning Breast Cancer, and by analogy all other diseases. Modern research continually introduces massive amounts of experimental data, clinical findings and text-based knowledge into the public domain. Demonstrations of diverse search strategies will be presented that effectively lead to discovery and validation of prognostic, diagnostic and therapeutic biomarkers and delineate drug class effects via gene and pathway perturbations.

You can Register to use the full featured application using your Harvard email at:
https://harvard.nextbio.com



----------------------------------------------------------------------------------------------------------------------



James Flynn, PhD
Field Application Scientist

NEXTBIO >
3 Results Way, Cupertino CA 95014
Mobile: 781-835-5917
Email: james@nextbio.com
Web: www.nextbio.com


Amy Reinhart
Manager of Research Operations
Department of Cell Biology
Harvard Medical School
LHRRB 116
45 Shattuck Street
Boston, MA 02115

617-432-0436